PL378875A1 - Zastosowania kompleksu żelaza i zestaw - Google Patents

Zastosowania kompleksu żelaza i zestaw

Info

Publication number
PL378875A1
PL378875A1 PL378875A PL37887503A PL378875A1 PL 378875 A1 PL378875 A1 PL 378875A1 PL 378875 A PL378875 A PL 378875A PL 37887503 A PL37887503 A PL 37887503A PL 378875 A1 PL378875 A1 PL 378875A1
Authority
PL
Poland
Prior art keywords
iron
administration
treatment
composition
restless legs
Prior art date
Application number
PL378875A
Other languages
English (en)
Other versions
PL206810B1 (pl
Inventor
Mary Jane Helenek
Ralf A. Lange
Fred B. Oldham
Marc L. Tokars
Original Assignee
Vifor (International) Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor (International) Ag filed Critical Vifor (International) Ag
Publication of PL378875A1 publication Critical patent/PL378875A1/pl
Publication of PL206810B1 publication Critical patent/PL206810B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Plant Substances (AREA)
PL378875A 2003-03-14 2003-05-13 Zastosowania kompleksu żelaza i zestaw PL206810B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/389,228 US6960571B2 (en) 2003-03-14 2003-03-14 Methods and compositions for administration of iron for the treatment of restless leg syndrome

Publications (2)

Publication Number Publication Date
PL378875A1 true PL378875A1 (pl) 2006-05-29
PL206810B1 PL206810B1 (pl) 2010-09-30

Family

ID=32962229

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378875A PL206810B1 (pl) 2003-03-14 2003-05-13 Zastosowania kompleksu żelaza i zestaw

Country Status (25)

Country Link
US (1) US6960571B2 (pl)
EP (1) EP1603580B1 (pl)
JP (2) JP2006520322A (pl)
KR (1) KR100978377B1 (pl)
CN (1) CN1771044B (pl)
AT (1) ATE400280T1 (pl)
AU (1) AU2003249635C1 (pl)
BR (1) BR0318185A (pl)
CA (1) CA2518971C (pl)
CY (1) CY1110407T1 (pl)
DE (1) DE60322121D1 (pl)
DK (1) DK1603580T3 (pl)
ES (1) ES2309403T3 (pl)
HR (1) HRP20050796A2 (pl)
IL (1) IL170386A (pl)
MX (1) MXPA05009786A (pl)
NO (1) NO20054728L (pl)
PL (1) PL206810B1 (pl)
PT (1) PT1603580E (pl)
RS (1) RS51823B (pl)
RU (1) RU2319490C2 (pl)
SI (1) SI1603580T1 (pl)
UA (1) UA83483C2 (pl)
WO (1) WO2004082693A1 (pl)
ZA (1) ZA200508308B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
EP1655040A1 (en) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Contrast agent formulations for the visualization of the lymphatic system
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
KR20080078075A (ko) * 2005-12-20 2008-08-26 세레우사이언스 아베 하지 불안 증후군의 치료 및 진단을 위한 방법 및 조성물
ES2634142T3 (es) * 2005-12-23 2017-09-26 Ajay Gupta Composición de nutrición parenteral que contiene hierro
AU2016205002C1 (en) * 2006-01-06 2020-09-24 Vifor (International) Ag Methods and compositions for administration of iron
WO2007081744A2 (en) * 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
AU2013206429B2 (en) * 2006-01-06 2016-04-28 Vifor (International) Ag Methods and compositions for administration of iron
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
EP1941869A1 (en) * 2007-01-04 2008-07-09 Vifor (International) Ag Multicompartment bag for storage of iron preparations
JP2011516419A (ja) * 2008-03-28 2011-05-26 カイナ エルエルシー 鉄欠乏性障害を治療するためのフェリチンの使用
US20110226658A1 (en) * 2008-05-23 2011-09-22 Hospira, Inc. Packaged Iron Sucrose Products
CN102395595A (zh) * 2008-11-06 2012-03-28 生物链接治疗股份有限公司 不宁腿综合症和睡眠障碍的治疗
BRPI0924653B8 (pt) 2009-03-25 2021-05-25 Pharmacosmos Holding As composto de ferro-oligossacarídeo, composição e uso de deste composto
US8058076B2 (en) * 2009-03-31 2011-11-15 Astron Research Limited In-vitro method for testing bioequivalence of iron-sucrose formulation
CN102440999A (zh) * 2010-10-15 2012-05-09 天津瑞普生物技术股份有限公司 一种用于防治仔猪缺铁性贫血、低过敏反应的复方药物
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
CA2904357C (en) 2013-03-15 2020-09-22 Intrinsic Lifesciences Llc Anti-hepcidin antibodies and uses thereof
JP2014132029A (ja) * 2014-04-03 2014-07-17 Chyna Llc 鉄欠乏性障害を治療するためのフェリチンの使用
CA2961917A1 (en) 2014-09-22 2016-03-31 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
WO2016069950A2 (en) * 2014-10-29 2016-05-06 University Of Utah Research Foundation Methods of treating hypoxia-associated optical conditions with cartilage oligo matrix protein-angiopoietin 1 (comp-ang1)
EP2913054A1 (en) 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of restless leg syndrome (rls)
JP2024534172A (ja) 2021-08-27 2024-09-18 ヴァイフォー（インターナショナル）アーゲー 鉄組成物並びにそれらを作製及び使用する方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248492A (en) * 1986-07-03 1993-09-28 Advanced Magnetics, Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5700832A (en) * 1994-10-19 1997-12-23 Daewon Pharm. Co., Ltd. Antianemic agent containing iron and difructose
RU2153351C2 (ru) * 1995-12-14 2000-07-27 Закрытое акционерное общество "ВАМ" Средство для регулирования эндогенной продукции цитокинов и гемопоэтических факторов (варианты) и способ его использования
SE9803760D0 (sv) 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
AU2001251306A1 (en) 2000-04-04 2001-10-15 Siegel, Jerome M. Treatment of sleep disorders with hypocretin-1

Also Published As

Publication number Publication date
RS20050695A (sr) 2008-04-04
AU2003249635B2 (en) 2009-06-04
CN1771044B (zh) 2012-09-19
PL206810B1 (pl) 2010-09-30
MXPA05009786A (es) 2006-03-08
KR100978377B1 (ko) 2010-08-30
ATE400280T1 (de) 2008-07-15
US6960571B2 (en) 2005-11-01
HK1089666A1 (en) 2006-12-08
CY1110407T1 (el) 2015-04-29
CA2518971A1 (en) 2004-09-30
WO2004082693A1 (en) 2004-09-30
HRP20050796A2 (en) 2005-12-31
RS51823B (sr) 2012-02-29
US20040180849A1 (en) 2004-09-16
JP2010180252A (ja) 2010-08-19
DE60322121D1 (de) 2008-08-21
DK1603580T3 (da) 2008-10-06
SI1603580T1 (sl) 2009-04-30
RU2319490C2 (ru) 2008-03-20
EP1603580A1 (en) 2005-12-14
BR0318185A (pt) 2006-03-21
NO20054728D0 (no) 2005-10-13
JP2006520322A (ja) 2006-09-07
CA2518971C (en) 2009-02-17
ZA200508308B (en) 2006-10-25
AU2003249635C1 (en) 2009-11-05
CN1771044A (zh) 2006-05-10
EP1603580B1 (en) 2008-07-09
ES2309403T3 (es) 2008-12-16
AU2003249635A1 (en) 2004-10-11
RU2005131832A (ru) 2006-03-20
KR20060082032A (ko) 2006-07-14
PT1603580E (pt) 2008-09-10
UA83483C2 (uk) 2008-07-25
IL170386A (en) 2013-03-24
NO20054728L (no) 2005-12-13

Similar Documents

Publication Publication Date Title
CY1110407T1 (el) Συνθεση για χορηγηση σιδηρου για την θεραπεια του συνδρομου σπασμωδικου σκελους
EP1670450A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
HRP20041071A2 (en) Methods of treating hepatitis
JO2475B1 (en) Glucokinase stimulants
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
AU7194101A (en) Treatment of glycogen storage disease type ii
MX2007003812A (es) Inhibicion de proteasa ns3-ns4a del virus de la hepatitis c (vhc).
NZ522368A (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
IL188176A0 (en) Stable pharmaceutical composition comprising linezolid form iv
UA81625C2 (ru) Применение ротиготина для трансепикутального лечения синдрома уставших ног
PL2526934T3 (pl) Inhibitory kinazy tyrozynowej Brutona
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
DK1030667T3 (da) Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
TW200514582A (en) Transdermal preparation and method for reducing side effect in pergolide therapy
MXPA04007064A (es) Metodo para la produccion de pseudoisletas.
UA50328A (uk) Спосіб лікування атоній передшлунків великої рогатої худоби
UA42532A (uk) Спосіб лікування сальмонельозного менінгіту тифімуріум у дітей раннього віку
MD994G2 (ro) Metodă de corecţie a secreţiei gastrice acide în patologia gastrointestinală
UA50298A (uk) Спосіб лікування синдрому діабетичної стопи
UA49213A (uk) Спосіб лікування передчасного телархе

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130513